Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) Debt to equity

Solventum Corporation's debt to equity at the end of the quarter to 30 June 2026 was 1.1×, up 0.1× from fiscal 2025 (1.0×). That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Annual

Period Debt to equity Change
FY2025 1.0× (63.16%)
FY2024 2.7× —
FY2023 0.0× —
FY2022 0.0× —

Quarterly

Period Debt to equity Change
Jun 2026 1.1× 3.51%
Mar 2026 1.1× 6.70%
Dec 2025 1.0× (3.21%)
Sep 2025 1.0× (51.94%)
11 more quarters

Debt to equity against peers

Company Debt to equity
ALGN Align Technology, Inc. compare 0.0×
WST West Pharmaceutical Services, Inc. compare 0.1×
ALC Alcon compare 0.2×
RGEN Repligen Corporation compare 0.3×
COO The Cooper Companies, Inc. compare 0.3×
ATR AptarGroup, Inc. compare 0.5×
AVTR Avantor, Inc. compare 0.7×
SOLV Solventum Corporation 1.1×
BAX Baxter International Inc. compare 1.5×
Medical Instruments & Supplies industry median 0.1×
Healthcare sector median 0.0×
Market median 0.2×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on SOLV